These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 32810152)

  • 21. Quorum quenching quandary: resistance to antivirulence compounds.
    Maeda T; García-Contreras R; Pu M; Sheng L; Garcia LR; Tomás M; Wood TK
    ISME J; 2012 Mar; 6(3):493-501. PubMed ID: 21918575
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bacteriophage-antibiotic combination therapy for multidrug-resistant Pseudomonas aeruginosa: In vitro synergy testing.
    Holger DJ; Lev KL; Kebriaei R; Morrisette T; Shah R; Alexander J; Lehman SM; Rybak MJ
    J Appl Microbiol; 2022 Sep; 133(3):1636-1649. PubMed ID: 35652690
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Combined Treatment of 6-Gingerol Analog and Tobramycin for Inhibiting Pseudomonas aeruginosa Infections.
    Ham SY; Kim HS; Jo MJ; Lee JH; Byun Y; Ko GJ; Park HD
    Microbiol Spectr; 2021 Oct; 9(2):e0019221. PubMed ID: 34704784
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adjuvant effect of cranberry proanthocyanidin active fraction on antivirulent property of ciprofloxacin against Pseudomonas aeruginosa.
    Vadekeetil A; Alexandar V; Chhibber S; Harjai K
    Microb Pathog; 2016 Jan; 90():98-103. PubMed ID: 26620081
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Potential synergistic activity of quercetin with antibiotics against multidrug-resistant clinical strains of Pseudomonas aeruginosa.
    Vipin C; Saptami K; Fida F; Mujeeburahiman M; Rao SS; Athmika ; Arun AB; Rekha PD
    PLoS One; 2020; 15(11):e0241304. PubMed ID: 33156838
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Down-regulatory effects of green coffee extract on las I and las R virulence-associated genes in Pseudomonas aeruginosa.
    Jamalifar H; Samadi N; Nowroozi J; Dezfulian M; Fazeli MR
    Daru; 2019 Jun; 27(1):35-42. PubMed ID: 31187452
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Activity of meropenem with and without ciprofloxacin and colistin against Pseudomonas aeruginosa and Acinetobacter baumannii.
    Pankuch GA; Lin G; Seifert H; Appelbaum PC
    Antimicrob Agents Chemother; 2008 Jan; 52(1):333-6. PubMed ID: 17967915
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Furvina inhibits the 3-oxo-C12-HSL-based quorum sensing system of Pseudomonas aeruginosa and QS-dependent phenotypes.
    Borges A; Sousa P; Gaspar A; Vilar S; Borges F; Simões M
    Biofouling; 2017 Feb; 33(2):156-168. PubMed ID: 28140677
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy of sub-MIC level of meropenem and ciprofloxacin against extensive drug-resistant (XDR) Pseudomonas aeruginosa isolates of diabetic foot ulcer patients.
    Srivastava P; Sivashanmugam K
    Infect Genet Evol; 2021 Aug; 92():104824. PubMed ID: 33774177
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Combination Therapy Strategy of Quorum Quenching Enzyme and Quorum Sensing Inhibitor in Suppressing Multiple Quorum Sensing Pathways of P. aeruginosa.
    Fong J; Zhang C; Yang R; Boo ZZ; Tan SK; Nielsen TE; Givskov M; Liu XW; Bin W; Su H; Yang L
    Sci Rep; 2018 Jan; 8(1):1155. PubMed ID: 29348452
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of the Synergy of Ceftazidime-Avibactam in Combination with Meropenem, Amikacin, Aztreonam, Colistin, or Fosfomycin against Well-Characterized Multidrug-Resistant Klebsiella pneumoniae and Pseudomonas aeruginosa.
    Mikhail S; Singh NB; Kebriaei R; Rice SA; Stamper KC; Castanheira M; Rybak MJ
    Antimicrob Agents Chemother; 2019 Aug; 63(8):. PubMed ID: 31182535
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synergistic activity of sub-inhibitory concentrations of curcumin with ceftazidime and ciprofloxacin against Pseudomonas aeruginosa quorum sensing related genes and virulence traits.
    Roudashti S; Zeighami H; Mirshahabi H; Bahari S; Soltani A; Haghi F
    World J Microbiol Biotechnol; 2017 Mar; 33(3):50. PubMed ID: 28188589
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tobramycin Adaptation Enhances Policing of Social Cheaters in Pseudomonas aeruginosa.
    Abisado RG; Kimbrough JH; McKee BM; Craddock VD; Smalley NE; Dandekar AA; Chandler JR
    Appl Environ Microbiol; 2021 May; 87(12):e0002921. PubMed ID: 33837019
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chlorhexidine leads to the evolution of antibiotic-resistant Pseudomonas aeruginosa.
    Tag ElDein MA; Yassin AS; El-Tayeb O; Kashef MT
    Eur J Clin Microbiol Infect Dis; 2021 Nov; 40(11):2349-2361. PubMed ID: 34169445
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antimicrobial activity of novel chalcones and modulation of virulence factors in hospital strains of Acinetobacter baumannii and Pseudomonas aeruginosa.
    Ušjak D; Ivković B; Božić DD; Bošković L; Milenković M
    Microb Pathog; 2019 Jun; 131():186-196. PubMed ID: 30980878
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Itaconimides as Novel Quorum Sensing Inhibitors of
    Fong J; Mortensen KT; Nørskov A; Qvortrup K; Yang L; Tan CH; Nielsen TE; Givskov M
    Front Cell Infect Microbiol; 2018; 8():443. PubMed ID: 30666301
    [No Abstract]   [Full Text] [Related]  

  • 37. Reverting antibiotic tolerance of Pseudomonas aeruginosa PAO1 persister cells by (Z)-4-bromo-5-(bromomethylene)-3-methylfuran-2(5H)-one.
    Pan J; Bahar AA; Syed H; Ren D
    PLoS One; 2012; 7(9):e45778. PubMed ID: 23029239
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mutant prevention concentrations of levofloxacin alone and in combination with azithromycin, ceftazidime, colistin (Polymyxin E), meropenem, piperacillin-tazobactam, and tobramycin against Pseudomonas aeruginosa.
    Zhanel GG; Mayer M; Laing N; Adam HJ
    Antimicrob Agents Chemother; 2006 Jun; 50(6):2228-30. PubMed ID: 16723591
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro activities of non-traditional antimicrobials alone or in combination against multidrug-resistant strains of Pseudomonas aeruginosa and Acinetobacter baumannii isolated from intensive care units.
    Timurkaynak F; Can F; Azap OK; Demirbilek M; Arslan H; Karaman SO
    Int J Antimicrob Agents; 2006 Mar; 27(3):224-8. PubMed ID: 16464562
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Activity and Impact on Resistance Development of Two Antivirulence Fluoropyrimidine Drugs in
    Imperi F; Fiscarelli EV; Visaggio D; Leoni L; Visca P
    Front Cell Infect Microbiol; 2019; 9():49. PubMed ID: 30915278
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.